These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 28958755)

  • 1. Prognostic value of silent myocardial infarction in patients with chronic kidney disease being evaluated for kidney transplantation.
    Farag AA; AlJaroudi W; Neill J; Doppalapudi H; Kumar V; Rizk D; Iskandrian AE; Hage FG
    Int J Cardiol; 2017 Dec; 249():377-382. PubMed ID: 28958755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of silent myocardial infarction in patients with chronic kidney disease after kidney transplantation.
    Santana JC; Doppalapudi H; Ives CW; Farag AA; Rizk DV; Kumar V; Iskandrian AE; Hage FG
    Am J Transplant; 2022 Apr; 22(4):1115-1122. PubMed ID: 34967107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silent Myocardial Infarction and Long-Term Risk of Heart Failure: The ARIC Study.
    Qureshi WT; Zhang ZM; Chang PP; Rosamond WD; Kitzman DW; Wagenknecht LE; Soliman EZ
    J Am Coll Cardiol; 2018 Jan; 71(1):1-8. PubMed ID: 29301615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of silent myocardial infarction in newly diagnosed type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 79.
    Davis TM; Coleman RL; Holman RR;
    Circulation; 2013 Mar; 127(9):980-7. PubMed ID: 23362315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Race and Sex Differences in the Incidence and Prognostic Significance of Silent Myocardial Infarction in the Atherosclerosis Risk in Communities (ARIC) Study.
    Zhang ZM; Rautaharju PM; Prineas RJ; Rodriguez CJ; Loehr L; Rosamond WD; Kitzman D; Couper D; Soliman EZ
    Circulation; 2016 May; 133(22):2141-8. PubMed ID: 27185168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silent Cerebral Microbleeds and Longitudinal Risk of Renal and Cardiovascular Events in Patients with CKD.
    Shima H; Mori T; Ooi M; Sonoda M; Shoji T; Ishimura E; Okamura M; Ishizaka N; Inaba M
    Clin J Am Soc Nephrol; 2016 Sep; 11(9):1557-1565. PubMed ID: 27354659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrocardiographic QRS-T angle and the risk of incident silent myocardial infarction in the Atherosclerosis Risk in Communities study.
    Zhang ZM; Rautaharju PM; Prineas RJ; Tereshchenko L; Soliman EZ
    J Electrocardiol; 2017; 50(5):661-666. PubMed ID: 28515002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decline in 20-year mortality after myocardial infarction in patients with chronic kidney disease: evolution from the prethrombolysis to the percutaneous coronary intervention era.
    Nauta ST; van Domburg RT; Nuis RJ; Akkerhuis M; Deckers JW
    Kidney Int; 2013 Aug; 84(2):353-8. PubMed ID: 23486524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic kidney disease and diabetes associated with long-term outcomes in patients receiving percutaneous coronary intervention.
    Lin MJ; Lee J; Chen CY; Huang CC; Wu HP
    BMC Cardiovasc Disord; 2017 Sep; 17(1):242. PubMed ID: 28893175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Healthy lifestyle and risk of kidney disease progression, atherosclerotic events, and death in CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Ricardo AC; Anderson CA; Yang W; Zhang X; Fischer MJ; Dember LM; Fink JC; Frydrych A; Jensvold NG; Lustigova E; Nessel LC; Porter AC; Rahman M; Wright Nunes JA; Daviglus ML; Lash JP;
    Am J Kidney Dis; 2015 Mar; 65(3):412-24. PubMed ID: 25458663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interrelations Between Serum Uric Acid, Silent Myocardial Infarction, and Mortality in the General Population.
    Ahmad MI; Dutta A; Anees MA; Soliman EZ
    Am J Cardiol; 2019 Mar; 123(6):882-888. PubMed ID: 30617009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revascularization in Patients With Multivessel Coronary Artery Disease and Chronic Kidney Disease: Everolimus-Eluting Stents Versus Coronary Artery Bypass Graft Surgery.
    Bangalore S; Guo Y; Samadashvili Z; Blecker S; Xu J; Hannan EL
    J Am Coll Cardiol; 2015 Sep; 66(11):1209-1220. PubMed ID: 26361150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additive prognostic value of coronary artery calcium score and renal function in patients with acute chest pain without known coronary artery disease: up to 5-year follow-up.
    Chaikriangkrai K; Nabi F; Mahmarian JJ; Chang SM
    Int J Cardiovasc Imaging; 2015 Dec; 31(8):1619-26. PubMed ID: 26243534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular events and all-cause mortality in a cohort of 57,946 patients with type 2 diabetes: associations with renal function and cardiovascular risk factors.
    Cea Soriano L; Johansson S; Stefansson B; Rodríguez LA
    Cardiovasc Diabetol; 2015 Apr; 14():38. PubMed ID: 25909295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonesterified fatty acids and cardiovascular mortality in elderly men with CKD.
    Xiong Z; Xu H; Huang X; Ärnlöv J; Qureshi AR; Cederholm T; Sjögren P; Lindholm B; Risérus U; Carrero JJ
    Clin J Am Soc Nephrol; 2015 Apr; 10(4):584-91. PubMed ID: 25637632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.
    Parikh PB; Jeremias A; Naidu SS; Brener SJ; Lima F; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):352-7. PubMed ID: 22566286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular and Renal Implications of Myocardial Infarction in the ISCHEMIA-CKD Trial.
    Chaitman BR; Cyr DD; Alexander KP; Pracoń R; Bainey KR; Mathew A; Acharya A; Kunichoff DF; Fleg JL; Lopes RD; Sidhu MS; Anthopolos R; Rockhold FW; Stone GW; Maron DJ; Hochman JS; Bangalore S
    Circ Cardiovasc Interv; 2022 Aug; 15(8):e012103. PubMed ID: 35973009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silent Myocardial Infarction and Long-Term Risk of Frailty: The Atherosclerosis Risk in Communities Study.
    Li F; Li D; Yu J; Jia Y; Liu Y; Liu Y; Wu Q; Liao X; Zeng Z; Wan Z; Zeng R
    Clin Interv Aging; 2021; 16():1139-1149. PubMed ID: 34168437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Silent Myocardial Infarction and Long-Term Risk of Sudden Cardiac Death.
    Cheng YJ; Jia YH; Yao FJ; Mei WY; Zhai YS; Zhang M; Wu SH
    J Am Heart Assoc; 2021 Jan; 10(1):e017044. PubMed ID: 33372536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic kidney disease and long-term outcomes of myocardial infarction.
    Nagashima M; Hagiwara N; Koyanagi R; Yamaguchi J; Takagi A; Kawada-Watanabe E; Shiga T; Ogawa H
    Int J Cardiol; 2013 Sep; 167(6):2490-5. PubMed ID: 22569317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.